[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Adverum Biotechnologies, Inc. Common Stock (ADVM)
Eli Lilly has completed its acquisition of Adverum Biotechnologies, with the deal structured around an upfront cash payment and a significant contingent value right (CVR). Concerns linger regarding the CVR's payout conditions, impacting current stock price despite the acquisition news.
About Adverum Biotechnologies, Inc. Common Stock
Adverum Biotechnologies, Inc. is a healthcare company focused on gene therapy for ocular diseases.
Adverum Biotechnologies, Inc. Common Stock uses the ticker $ADVM for trading. Listed in the Stocks category.
Insights
- Adverum Biotechnologies, Inc. Common Stock (ADVM) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Adverum Biotechnologies, Inc. Common Stock (ADVM) creators is up XXXXX% from the previous week.
- Adverum Biotechnologies, Inc. Common Stock (ADVM) engagements is up XXXXXX% from the previous week.
- Adverum Biotechnologies, Inc. Common Stock (ADVM) mentions is up XXXXX% from the previous week.
Price: $XXXX
Price 24-Hour Time-Series Raw Data
The stock is trading down due to concerns about the deal's structure, specifically the large contingent value right (CVR) component, overshadowing the positive acquisition news by Eli Lilly. Despite the acquisition news, the stock price has seen a XXXX% decrease in the last XX hours.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXX on 2025-03-20
1-Year Low: $XXXX on 2025-05-15
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Adverum Biotechnologies, Inc. Common Stock (ADVM) is currently AltRank #1,030 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +194
X Month: XXXXX +53
X Months: XXXXX -XXX
X Year: XXXXX +117
1-Year High: XXXXX on 2025-09-11
1-Year Low: XX on 2025-01-01
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -X
X Year: XX +3
1-Year High: XX on 2025-06-02
1-Year Low: XX on 2025-11-10
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +124%
X Month: XXXXXX -XX%
X Months: XXXXXXX +92%
X Year: XXXXXXX -XX%
1-Year High: XXXXXXX on 2025-10-24
1-Year Low: XX on 2025-04-08
Engagements by network (24h): Reddit: XXX X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +12%
X Month: XXX -XX%
X Months: XXXXX +141%
X Year: XXXXX -XXXX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-13
Mentions by network (24h): Reddit: XX X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Adverum Biotechnologies, Inc. Common Stock (ADVM) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +21%
X Month: XXX -XXXX%
X Months: XXXXX +204%
X Year: XXXXX +173%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-13
The most influential creators that mention Adverum Biotechnologies, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedytx19 | X | XXXXX | X | XX |
| @JeffTheOmega1 | X | XXXXX | X | XX |
| @schaeffers | X | XXXXXX | X | XX |
| @EarningsToday | X | XXX | X | XX |
| @Biobeats99 | X | XXX | X | XX |
| @prosperousguy | X | XXXXX | X | XX |
| @BiopharmIQ | X | XXXXXX | X | XX |
| @john_steel70462 | X | XXX | X | X |
| @Options_Edu | X | XXXXXX | X | X |
| @MarcJacksonLA | XX | XXXXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +76%
X Year: XX% +9%
1-Year High: XXX% on 2025-01-24
1-Year Low: X% on 2024-12-28
Most Supportive Themes:
- Eli Lilly Acquisition: (40%) Eli Lilly is acquiring Adverum Biotechnologies for up to $XXXXX per share, focusing on Adverum's lead candidate, Ixo-vec, for wet age-related macular degeneration.
- Gene Therapy Advancements: (30%) Adverum's Ixo-vec is a gene therapy for ocular diseases, highlighting the growing interest and investment in this sector.
- Market Catalysts & Watchlists: (20%) ADVM is frequently mentioned in biotech stock catalyst watchlists and unusual options activity reports, indicating trader interest.
Most Critical Themes:
- Deal Structure Concerns: (60%) Concerns exist about the deal structure, with a significant portion of the value tied to a contingent value right (CVR) that depends on FDA approval and substantial sales.
- Price Action Reaction: (40%) Despite positive news like the acquisition, the stock is trading red, suggesting market skepticism or reaction to specific deal terms.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
X Month: XXXXX% +0.025%
X Months: XXXXX% +0.024%
X Year: XXXXX% +0.024%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-09-13
Market Dominance: XXXXXXXXXXXXXXXXXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-19
1-Year Low: XXXXXXX% on 2025-05-13
Market Cap: $XXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXX
X Week: $XXXXXXXXXXX +$8.20%
X Month: $XXXXXXXXXX +$1.40%
X Months: $XXXXXXXXXX +$87%
X Year: $XXXXXXXXXX -$19%
1-Year High: $XXXXXXXXXXX on 2025-03-20
1-Year Low: $XXXXXXXXXX on 2025-05-15
Top Adverum Biotechnologies, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Buy Verified Bybit Accounts $FTNT $CRWV $DEO $SYM $ALAB $CRCL $RKLB $PTC $TPR $HUBS $UMC $OKLO $SNN $TEM $STRL $CELH $JHX $MNDY $CIFR $NVMI $PAYC $DUOL $CAI $FIGR $ICL $PRMB $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $SGMO $ADVM"
X Link @john_steel70462 2025-12-12T15:34Z XXX followers, XX engagements
"👨🏼💼 Top CEO buys today from SEC Filings 👉 Tickers: $AIRJ $BH $IMMX $DSAC $DSAC $ATEX $SRTA $SMRT $STRR $HKHC $DOMH $RVSB $NRDY $JFB $SVCO $RDGL $HKHC $RHEP $NRDY $MSCI $ROLR $ADVM $MDRR $XOMA $BPAC $DLPN $GMRE $EMBY $LIN $QNTO"
X Link @InsideDashboard 2025-12-11T02:52Z 1791 followers, XXX engagements
"Symbol Updates for December XX 2025: ➕ Additions (10): $AAEQ - EA Series Trust $AUAU - Global X Funds $CDNL - Cardinal Infrastructure Group Inc. $CSIO - Cohen & Steers ETF Trust $CSSD - Cohen & Steers ETF Trust $IALT - BlackRock ETF Trust $JMG - JM Group Limited $NLSI - NEOS ETF Trust $PLGI - Collaborative Investment Series Trust $WTIB - USCF ETF Trust ➖ Deletions (6): $ADVM - Adverum Biotechnologies Inc. $AKRO - Akero Therapeutics Inc. $ATMVR - AMC Robotics Corporation $ATMVU - AMC Robotics Corporation $RFL+ - Rafael Holdings Inc. $SCS - Steelcase Inc"
X Link @Yours_Edgar 2025-12-10T12:14Z XXX followers, XXX engagements
"@JusticeforB_MD $advs $advm also with insider buys and $bhvn with good call options activity in addition to $abvx Im still checking out $dmac Thanks"
X Link @Drchik23 2025-12-10T00:30Z 3756 followers, XXX engagements